Found: 30
Select item for more details and to access through your institution.
Alternative switching strategies based on regimens with a low genetic barrier: do clinicians have a choice nowadays?
- Published in:
- European Journal of Clinical Microbiology & Infectious Diseases, 2019, v. 38, n. 3, p. 423, doi. 10.1007/s10096-018-3429-x
- By:
- Publication type:
- Article
Changes in Quality of Sleep, Mood, and Other Neuropsychiatric Symptoms After Switching Dolutegravir/Lamivudine/Abacavir to Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in a Randomized Study of People With Human Immunodeficiency Virus With Poor Sleep Quality: GESIDA 10418
- Published in:
- Open Forum Infectious Diseases, 2022, v. 9, n. 9, p. 1, doi. 10.1093/ofid/ofac345
- By:
- Publication type:
- Article
Recurring Severe Injection-Related Infections in People Who Inject Drugs and the Need for Safe Injection Sites in Madrid, Spain.
- Published in:
- Open Forum Infectious Diseases, 2021, v. 8, n. 7, p. 1, doi. 10.1093/ofid/ofab251
- By:
- Publication type:
- Article
Infliximab Biosimilars: A Promising but Unusual Treatment for Mycobacterial Immune Reconstitution Inflammatory Syndrome in Human Immunodeficiency Virus-Infected Patients.
- Published in:
- Open Forum Infectious Diseases, 2017, v. 4, n. 3, p. 1, doi. 10.1093/ofid/ofx164
- By:
- Publication type:
- Article
Sexualized Drug Use (Chemsex) Is Associated with High-Risk Sexual Behaviors and Sexually Transmitted Infections in HIV-Positive Men Who Have Sex with Men: Data from the U-SEX GESIDA 9416 Study.
- Published in:
- AIDS Patient Care & STDs, 2018, v. 32, n. 3, p. 112, doi. 10.1089/apc.2017.0263
- By:
- Publication type:
- Article
MicroRNA Profile of HCV Spontaneous Clarified Individuals, Denotes Previous HCV Infection.
- Published in:
- Journal of Clinical Medicine, 2019, v. 8, n. 6, p. 849, doi. 10.3390/jcm8060849
- By:
- Publication type:
- Article
HIV screening and retention in care in people who use drugs in Madrid, Spain: a prospective study.
- Published in:
- Infectious Diseases of Poverty, 2021, v. 10, n. 1, p. 1, doi. 10.1186/s40249-021-00894-5
- By:
- Publication type:
- Article
Oral bulky lesions related to advanced HIV infection.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Epidemiological and Clinical Characteristics of Patients Admitted to a Secondary Hospital with Suspected MPOX Virus Infection: Is HIV Playing a Role?
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 12, p. 4124, doi. 10.3390/jcm12124124
- By:
- Publication type:
- Article
Myocardial Work Index in Professional Football Players: A Novel Method for Assessment of Cardiac Adaptation.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 9, p. 3059, doi. 10.3390/jcm12093059
- By:
- Publication type:
- Article
Predict the Effects of Dolutegravir (DTG) Plus Lamivudine (3TC) on Immunological Responses in People Living with HIV (PLWHIV).
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 3, p. 1176, doi. 10.3390/jcm12031176
- By:
- Publication type:
- Article
Differences in the hepatitis C virus cascade of care and time to initiation of therapy among vulnerable subpopulations using a mobile unit as point‐of‐care.
- Published in:
- Liver International, 2022, v. 42, n. 2, p. 309, doi. 10.1111/liv.15095
- By:
- Publication type:
- Article
Gender-based vulnerability in women who inject drugs in a harm reduction setting.
- Published in:
- PLoS ONE, 2020, v. 15, n. 3, p. 1, doi. 10.1371/journal.pone.0230886
- By:
- Publication type:
- Article
Efficacy and Safety of Two-Drug Regimens with Dolutegravir plus Rilpivirine or Lamivudine in HIV-1 Virologically Suppressed People Living with HIV.
- Published in:
- Viruses (1999-4915), 2023, v. 15, n. 4, p. 936, doi. 10.3390/v15040936
- By:
- Publication type:
- Article
Dolutegravir Plus 3TC in Virologically Suppressed PLWHIV: Immunological Outcomes in a Multicenter Retrospective Cohort in Spain during the COVID-19 Pandemic.
- Published in:
- Viruses (1999-4915), 2023, v. 15, n. 2, p. 322, doi. 10.3390/v15020322
- By:
- Publication type:
- Article
Low Lymphocytes and IFN-Neutralizing Autoantibodies as Biomarkers of COVID-19 Mortality.
- Published in:
- 2022
- By:
- Publication type:
- Letter
Neutralizing Autoantibodies to Type I IFNs in >10% of Patients with Severe COVID-19 Pneumonia Hospitalized in Madrid, Spain.
- Published in:
- Journal of Clinical Immunology, 2021, v. 41, n. 5, p. 914, doi. 10.1007/s10875-021-01036-0
- By:
- Publication type:
- Article
Correction: Abacavir/Lamivudine plus Rilpivirine Is an Effective and Safe Strategy for HIV-1 Suppressed Patients: 48 Week Results of the SIMRIKI Retrospective Study.
- Published in:
- 2017
- By:
- Publication type:
- Correction Notice
Abacavir/Lamivudine plus Rilpivirine Is an Effective and Safe Strategy for HIV-1 Suppressed Patients: 48 Week Results of the SIMRIKI Retrospective Study.
- Published in:
- PLoS ONE, 2016, v. 11, n. 10, p. 1, doi. 10.1371/journal.pone.0164455
- By:
- Publication type:
- Article
Comparison of Noninvasive Cardiac Test Strategies for Newly Diagnosed Chagas Disease in a Non-Endemic Zone.
- Published in:
- American Journal of Tropical Medicine & Hygiene, 2020, v. 103, n. 4, p. 1480, doi. 10.4269/ajtmh.20-0389
- By:
- Publication type:
- Article
Health care issues affecting transgender people living with HIV: an opportunity for improvement.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Mephedrone and chemsex: when it stops being a party and becomes a fatal problem.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Safety and Tolerability: Current Challenges to Antiretroviral Therapy for the Long-Term Management of HIV Infection.
- Published in:
- AIDS Reviews, 2016, v. 18, n. 3, p. 127
- By:
- Publication type:
- Article
Aortic thrombus in patients with severe COVID-19: review of three cases.
- Published in:
- Journal of Thrombosis & Thrombolysis, 2021, v. 51, n. 1, p. 237, doi. 10.1007/s11239-020-02219-z
- By:
- Publication type:
- Article
HCV seroconversion in a cohort of people who use drugs followed in a mobile harm reduction unit in Madrid: Breaking barriers for HCV elimination.
- Published in:
- PLoS ONE, 2018, v. 13, n. 10, p. 1, doi. 10.1371/journal.pone.0204795
- By:
- Publication type:
- Article
Raltegravir plus abacavir/lamivudine in virologically suppressed HIV-1-infected patients: 48-week results of the KIRAL study.
- Published in:
- PLoS ONE, 2018, v. 13, n. 6, p. 1, doi. 10.1371/journal.pone.0198768
- By:
- Publication type:
- Article
Real-life data of immune recovery using bictegravir/emtricitabine/tenofovir alafenamide in virologically suppressed people living with HIV. Results at 48–96 weeks of RETROBIC Study.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2024, v. 79, n. 3, p. 595, doi. 10.1093/jac/dkae011
- By:
- Publication type:
- Article
Switching to bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) plus darunavir/cobicistat in heavily antiretroviral-experienced, virologically suppressed HIV-infected adults receiving complex regimens.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, n. 11, p. 2696, doi. 10.1093/jac/dkad285
- By:
- Publication type:
- Article
A predictive model of immune recovery for DTG + 3TC and DTG + RPV used as switching strategies in HIV+ patients.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2022, v. 77, n. 12, p. 3519, doi. 10.1093/jac/dkac354
- By:
- Publication type:
- Article
Effectiveness and safety of an abacavir/lamivudine + rilpivirine regimen for the treatment of HIV-1 infection in naive patients.
- Published in:
- 2016
- By:
- Publication type:
- journal article